What Can Economics Say about Alzheimer's Disease?
Alzheimer's disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD.
Alzheimer's disease (AD) affects one in ten people aged 65 or older and is the most expensive disease in the United States. We describe the central economic questions raised by AD.
The following conversations stem from a 2018 workshop in Karlsruhe on “Access to the Future – Towards a Hermeneutic Perspective on Socio-Technical Change.” It was dedicated to the epistemological and
The following conversations stem from a 2018 workshop in Karlsruhe on “Access to the Future – Towards a Hermeneutic Perspective on Socio-Technical Change.” It was dedicated to the epistemological and
Millions of people in the U.S. every year are required to attend mandatory court dates as their cases proceed through the criminal legal system.
7:00 AM, the alarm goes off. 8:00 AM, you have a cup of coffee, scan the news, and check your email on your phone.
With the rise of far-reaching technological innovation, from artificial intelligence to Big Data, human life is increasingly unfolding in digital lifeworlds.
People with important evidence-based ideas often struggle to translate data into stories their readers can relate to and understand.
Over 2009-2019 the seemingly inexorable rise in health care’s share of GDP markedly slowed, both in the US and elsewhere.
There is a growing amount of evidence that machine learning (ML) algorithms can be used to develop accurate clinical risk scores for a wide range of medical conditions.
As a major public health crisis, the opioid epidemic caused over 556,000 deaths in the U.S. between 2000 and 2020.
Get smart & reliable public policy insights right in your inbox.